Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder
Clinical trial NCT00100776 · COMPLETED
Trial details
- NCT number
- NCT00100776
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.